Women with Borderline Ovarian Tumors Can Still Conceive Following Fertility-Sparing Surgery

Women receiving fertility-sparing surgery (FFS) for borderline ovarian tumors were still able to conceive, according to the findings of a study published in Fertility & Sterility.

In this study, comprised of 213 women who underwent FSS between 2008 and 2015 in Sweden, 23% had given birth to 62 babies after treatment, while 20 women, or 9% of the cohort – had undergone assisted reproduction (IVF). The women who had given birth after FSS were followed for 76 months, while the women who had not given birth were followed for 58 months.

According to the results, the survival rate for the entire cohort of 277 women was 99%, and the researchers was no difference between those who had received FSS and those who had undergone radical surgical cancer treatment. “The ability to become pregnant seems to be preserved with fertility-sparing surgery, a knowledge that is absolutely critical for the advice and treatment given to young women with ovarian borderline tumors,” says the study’s first author Gry Johansen, doctoral student at the Department of Oncology-Pathology, Karolinska Institutet via a press release.

“In the choice of treatment for borderline ovarian tumors, safety and the effectiveness for future childbearing must be taken into account,” says the study’s last author Kenny Rodriguez-Wallberg, researcher at the Department of Oncology-Pathology, Karolinska Institutet.